Cargando…
Real-Life Efficacy of Bevacizumab Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion according to Pro Re Nata or Treat-and-Extend Regimen in Eyes with or without Epiretinal Membrane
PURPOSE: To present real-life data of patients with macular edema (ME) secondary to central retinal vein occlusion (CRVO) treated with bevacizumab (BVZ); determine the possible influence of epiretinal membrane (ERM) on treatment efficacy; and compare treatment outcomes in a treat-and-extend regimen...
Autores principales: | Hamam, Moustafa, Lagali, Neil, Abdulnour, Elie, Setterud, Helen, Johansson, Björn, Mirabelli, Pierfrancesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550471/ https://www.ncbi.nlm.nih.gov/pubmed/36225608 http://dx.doi.org/10.1155/2022/6288582 |
Ejemplares similares
-
Grid laser with modified pro re nata injection of bevacizumab and ranibizumab in macular edema due to branch retinal vein occlusion: MARVEL report no 2
por: Narayanan, Raja, et al.
Publicado: (2016) -
Short term effect of intravitreal bevacizumab for diabetic macular edema associated with epiretinal membrane
por: Maryam, Ashraf Khorasani, et al.
Publicado: (2018) -
The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen
por: Takamura, Yoshihiro, et al.
Publicado: (2021) -
Treat-and-Extend vs. Pro Re Nata Regimen of Ranibizumab for Diabetic Macular Edema—A Two-Year Matched Comparative Study
por: Lai, Tso-Ting, et al.
Publicado: (2022) -
Pseudophakic macular edema involving epiretinal proliferation associated with macular hole
por: Batıoğlu, Figen, et al.
Publicado: (2020)